Ravi S. Chari, SVP-Clinical Excellence at HCA Holdings, Inc. (HCA), sold 15,901 shares at $82.00 ($1.3M) on 2017-02-01, disclosed to the SEC on 2017-02-03.
Open-market sale of $1.3M HCA by SVP-Clinical Excellence. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.